A Multi-Omics and machine learning platelet-related prognostic signature in multiple myeloma
Annals of Hematology · 2026
DOI: 10.1007/s00277-026-06867-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, 2026. Verfasst von Xiaojing Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, 35…. Hauptthemen laut MEDLINE: Multiple Myeloma, Machine Learning, Blood Platelets. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: government-funded project of the construction of high-level laboratory, Construction Project of Fujian medical center of hematology, National and Fujian Provincial Key Clinical Specialty Discipline Construction Program, P.R.C.
Abstract (Originalsprache)
While platelets are well-documented contributors to tumorigenesis, their role in multiple myeloma (MM) progression and risk stratification remains underexplored. To assess platelet function in MM and verify the prognostic value of platelet-related genes(PRGs) in patients with multiple myeloma, further providing new ideas for the development of MM. We combined the clinical assessment of platelet activation in MM patients with functional co-culture experiments using MM cell lines (RPMI8226, MM.1 S) to investigate platelet-driven tumor progression. Additionally, an integrated analysis of bulk (GSE124310) and single-cell transcriptomic datasets (GSE6477, TCGA-MM data, GSE4581, GSE24080,and GSE136337) was performed to identify platelet-related prognostic genes (PRGs). Through single-cell RNA sequencing, we identified aberrant erythroid-megakaryocyte components in multiple myeloma and further demonstrated dysfunctional platelet activity that promotes tumor cell proliferation and suppresses apoptosis. Using comprehensive bioinformatic screening across 116 algorithms, we identified a combined forward stepwise Cox and Ridge regression model as optimal and established a 13-gene platelet-related prognostic signature. The genetic risk model effectively stratified MM patients into distinct prognostic groups, with high-risk patients exhibiting poorer outcomes in both training and validation cohorts. Finally, we integrated the genetic risk model and clinically relevant information and visualized it with dynamic Nomogram plots, and the ROC and DCA curves demonstrated that the integrated model had better predictive ability. Our study establishes a significant association between platelet activity and disease progression in MM. The platelet-related prognostic signature we developed is correlated with patient outcomes and may have utility in risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, 350001, China.
- Department of Hematology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan, 250012, China.
- Fujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, 350001, China. nainli@aliyun.com.
- Department of Hematology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan, 250012, China. zhouhaisdu@163.com.
- Fujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, 350001, China. lycp428@163.com.
- Department of Infectious Disease, Fujian Medical University Union Hospital, Fuzhou, China. lycp428@163.com.
Förderung
- government-funded project of the construction of high-level laboratory
- Construction Project of Fujian medical center of hematology
- National and Fujian Provincial Key Clinical Specialty Discipline Construction Program, P.R.C
Zitieren
APA
Li, X., Xiao, Q., Wang, K., Lin, X., He, Y. A., Peng, J., Li, N., Zhou, H., & Chen, P. (2026). A Multi-Omics and machine learning platelet-related prognostic signature in multiple myeloma. Annals of Hematology. https://doi.org/10.1007/s00277-026-06867-8
Vancouver
Li X, Xiao Q, Wang K, Lin X, He YA, Peng J, et al. A Multi-Omics and machine learning platelet-related prognostic signature in multiple myeloma. Annals of Hematology. 2026. doi:10.1007/s00277-026-06867-8
BibTeX
@article{Li2026,
author = {Li, Xiaojing and Xiao, Qirong and Wang, Kuangfei and Lin, Xiaobin and He, Yu-An and Peng, Jun and Li, Nainong and Zhou, Hai and Chen, Ping},
title = {A Multi-Omics and machine learning platelet-related prognostic signature in multiple myeloma},
journal = {Annals of Hematology},
year = {2026},
doi = {10.1007/s00277-026-06867-8}
}
EUVIMED